GB9613457D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9613457D0
GB9613457D0 GBGB9613457.2A GB9613457A GB9613457D0 GB 9613457 D0 GB9613457 D0 GB 9613457D0 GB 9613457 A GB9613457 A GB 9613457A GB 9613457 D0 GB9613457 D0 GB 9613457D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9613457.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to GBGB9613457.2A priority Critical patent/GB9613457D0/en
Publication of GB9613457D0 publication Critical patent/GB9613457D0/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB9613457.2A 1996-06-27 1996-06-27 Pharmaceutical compositions Pending GB9613457D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions
BR9709997A BR9709997A (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of an nosid and a xanthine derivative
IL12742697A IL127426D0 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and xanthine derivative
AU36438/97A AU3643897A (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
CZ984091A CZ409198A3 (en) 1996-06-27 1997-06-24 Local gel preparation and application thereof
NZ333180A NZ333180A (en) 1996-06-27 1997-06-24 Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent
CA002258199A CA2258199A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
KR1019980710665A KR20000022245A (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
TR1998/02701T TR199802701T2 (en) 1996-06-27 1997-06-24 An NSAID, and a combination of topical gel composition containing a xanthine derivative.
EP97933190A EP0973522A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
PCT/US1997/011205 WO1997049405A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
HU9903835A HU9903835A3 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative
JP10503550A JPH11513037A (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a non-steroidal anti-inflammatory agent and a xanthine derivative
NO986042A NO986042L (en) 1996-06-27 1998-12-22 Topical gel composition containing a combination of NSAID and a xanthine derivative

Publications (1)

Publication Number Publication Date
GB9613457D0 true GB9613457D0 (en) 1996-08-28

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9613457.2A Pending GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions

Country Status (14)

Country Link
EP (1) EP0973522A1 (en)
JP (1) JPH11513037A (en)
KR (1) KR20000022245A (en)
AU (1) AU3643897A (en)
BR (1) BR9709997A (en)
CA (1) CA2258199A1 (en)
CZ (1) CZ409198A3 (en)
GB (1) GB9613457D0 (en)
HU (1) HU9903835A3 (en)
IL (1) IL127426D0 (en)
NO (1) NO986042L (en)
NZ (1) NZ333180A (en)
TR (1) TR199802701T2 (en)
WO (1) WO1997049405A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HU9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Also Published As

Publication number Publication date
AU3643897A (en) 1998-01-14
KR20000022245A (en) 2000-04-25
BR9709997A (en) 1999-08-10
NO986042D0 (en) 1998-12-22
NO986042L (en) 1999-02-26
HU9903835A3 (en) 2001-03-28
CA2258199A1 (en) 1997-12-31
CZ409198A3 (en) 1999-04-14
IL127426D0 (en) 1999-10-28
TR199802701T2 (en) 1999-03-22
HU9903835A2 (en) 2000-10-28
WO1997049405A1 (en) 1997-12-31
JPH11513037A (en) 1999-11-09
EP0973522A1 (en) 2000-01-26
NZ333180A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
HK1019544A1 (en) Composition
EG24435A (en) Novel pharmaceutical composition
PL175210B1 (en) New pharmaceutical compositions
CY2506B1 (en) Composition
DE69736066D1 (en) Pharmaceutical compositions contain s - (-) - n-propargyl-1-aminoindane
HRP970100B1 (en) Pharmaceutical composition for immunomodulation
EP0956854A4 (en) Pharmaceutical composition comprising coenzyme q 10
HK1022652A1 (en) Aqueous-based pharmaceutical composition
HU9903759A3 (en) Abtimicrobial compositions
EP0957903A4 (en) Pharmaceutical compositions and methods
AP9500733A0 (en) Pharmaceutical formulations
HU9400107D0 (en) Nanocapsule-contaning pharmaceutical compositions
HU9601698D0 (en) Pharmaceutical composition
AU3924895A (en) Pharmaceutical compositions
AU3553097A (en) Pharmaceutical composition
IL122447D0 (en) Pharmaceutical composition with anaestheric effect
AU3845195A (en) Pharmaceutical compositions
EP1073439A4 (en) Pharmaceutical composition
GB9713149D0 (en) Pharmaceutical formulations
GB9602080D0 (en) Pharmaceutical compounds
ZA946262B (en) Pharmaceutical compositions
GB9626513D0 (en) A pharmaceutical composition
IL181059A (en) Pharmaceutical compositions containing isoflavones
GB9600426D0 (en) Compositions
PT874621E (en) Pharmaceutical compositions